Clinical Trial Update: Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing idelalisib plus obinutuzumab versus chlorambucil plus obinutuzumab in previously untreated chronic lymphocytic leukemia; terminated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Idelalisib (idelalisib)
• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Lymphocytic Leukemia | Phase 3 | Status: TERMINATED | Results posted: 2017-06-28